Scientists have developed a once-a-day nasal gel formulation for the delivery of insulin that could put an end to injections for Type 1 diabetes sufferers. In results published today in the Royal ...

SALT LAKE CITY - Lipocine Inc. (NASDAQ:LPCN) has dosed the first patient in its pivotal Phase 3 clinical trial of LPCN 1154, an investigational oral formulation of brexanolone for postpartum ...

Marshall pitcher and Ona native Kenyon Collins has had a phenomenal start to his summer season with the Tri-State Coal Cats, yet to allow an earned run in his two appearances this season and ...

This study aims to test if oral insulin can influence metabolic parameters and intestinal weight in obese non-diabetic rats. Methods: Twelve weeks old Wistar rats were divided in 3 groups: control ...